Quest Diagnostics
$14.99 B
Share price
Change (1 day)
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Number of shares outstanding for Quest Diagnostics (DGX)

Number of shares outstanding as of May 2023 : 113,000,000

According to Quest Diagnostics 's latest financial reports and stock price the company's current number of shares outstanding is 113,000,000. At the end of 2022 the company had 113,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Quest Diagnostics from 2001 to 2022

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20220.11 B-7.38%
20210.12 B-9.63%
20200.13 B0.75%
20190.13 B-1.47%
20180.13 B
20170.13 B-1.45%
20160.13 B-3.5%
20150.14 B-1.38%
20140.14 B-0.68%
20130.14 B-8%
20120.15 B0.57%
20110.15 B-8.89%
20100.17 B-6.43%
20090.18 B-5.06%
20080.19 B0.82%
20070.19 B-1.92%
20060.19 B-2.72%
20050.20 B100.19%
20040.10 B-3.38%
20030.10 B8.14%
200296.9 M3.77%
200193.38 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
88,400,000-21.77%๐Ÿ‡บ๐Ÿ‡ธ USA
62,908,800-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
5,681,000-94.97%๐Ÿ‡บ๐Ÿ‡ธ USA
125,026,000 10.64%๐Ÿ‡บ๐Ÿ‡ธ USA
227,894,000 101.68%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
48,729,000-56.88%๐Ÿ‡บ๐Ÿ‡ธ USA